Urologix, Inc., based in Minneapolis, Minnesota develops, manufactures and markets minimally invasive urological treatment products. Urologix has developed and offers non-surgical, catheter-based treatments that use proprietary microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix is a leader in less invasive technology for the BPH treatment, with more than 225,0001 patients treated to date.Urologix' patented Cooled ThermoTherapy™ technology is creating effective2 treatment options for a wide range of patients with BPH. Cooled ThermoTherapy enlarged prostate treatment delivers precisely targeted microwave energy that heats and destroys enlarged prostatic tissue while unique cooling mechanisms protect surrounding healthy tissue. This benign prostatic hyperplasia treatment also enhances patient comfort.